Simon Turton

Simon Turton is a Senior Independent Non-executive Director at Midatech Pharma. Simon has previously served as Chairman at Playrise Digital, Q-Chip and OpsiRx Pharmaceuticals, and Managing Director at Warburg Pincus.

Simon has over 25 years of experience in the pharmaceutical and healthcare industries. Simon has a proven track record in successfully leading and growing companies. Simon has a deep understanding of the challenges and opportunities in the healthcare sector and is passionate about improving patient outcomes through innovative products and therapies.

Simon has played a key role in the development and commercialization of many groundbreaking products and therapies, including Q-Chip’s proprietary technology, which enables best-in-class molecules to be delivered more effectively. Simon was instrumental in the successful merger of Q-Chip and OpsiRx Pharmaceuticals into Midatech as the combined company went public on AIM.

Simon is a respected leader in the healthcare industry and is dedicated to improving patient care through innovative products and therapies.

Simon Turton has an MBA from INSEAD and a PhD in Pharmacy from the University of London.